Third-quarter revenue from continuing operations of $3.71 billion increased 3% on a reported basis and 2% on a constant currency basis, ahead of the company’s previously issued.
Tuberculous Meningitis Treatment MarketA recently published study by FMI expects the global tuberculous meningitis treatment market to augment at a 7.2% CAGR from 2023 to 2033. The global tuberculous meningitis treatment market garnered a market value of US$ 150 Billion in 2023, by the end of the said assessment per.
NEW YORK, Sept. 5, 2023 /PRNewswire/ Pomerantz LLP is investigating claims on behalf of investors of Baxter International Inc. . Such investors are advised to contact Robert S. Willoughby.